Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: Minimum of three-year follow-up in 145 patients
- 1 January 1990
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 119 (1), 8-14
- https://doi.org/10.1016/s0002-8703(05)80074-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillationJournal of the American College of Cardiology, 1989
- Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmiasJournal of the American College of Cardiology, 1983
- Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: Dosage experienceAmerican Heart Journal, 1983
- Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias.Circulation, 1983
- Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.Circulation, 1983
- Side effects of long-term amiodarone therapy.Circulation, 1983
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- Characteristics of the resuscitated out-of-hospital cardiac arrest victim with coronary heart disease.Circulation, 1981
- Clinical efficacy of amiodarone as an antiarrhythmic agentThe American Journal of Cardiology, 1976
- Survival after Resuscitation from Out-of-Hospital Ventricular FibrillationCirculation, 1974